The utility of circulating markers to predict bone loss across the CKD spectrum.
作者信息
Nickolas Thomas L
机构信息
Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York, New York
出版信息
Clin J Am Soc Nephrol. 2014 Jul;9(7):1160-2. doi: 10.2215/CJN.04660514. Epub 2014 Jun 19.
Abstract
摘要
相似文献
1
The utility of circulating markers to predict bone loss across the CKD spectrum.循环标志物在预测慢性肾脏病全病程中骨质流失方面的效用。
Clin J Am Soc Nephrol. 2014 Jul;9(7):1160-2. doi: 10.2215/CJN.04660514. Epub 2014 Jun 19.
2
Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.慢性肾脏病透析患者骨量丢失的骨密度及血清生化预测指标
Clin J Am Soc Nephrol. 2014 Jul;9(7):1254-62. doi: 10.2215/CJN.09470913. Epub 2014 Jun 19.
3
Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.慢性肾脏病 5 期患者 2 年皮质骨和小梁骨丢失：生化和临床预测因素。
Osteoporos Int. 2018 Jan;29(1):125-134. doi: 10.1007/s00198-017-4228-4. Epub 2017 Oct 9.
4
Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.CKD 患者的骨折：欧洲钙化组织协会和欧洲肾脏协会肾脏病透析与移植分会成员的综述
Kidney Int. 2017 Dec;92(6):1343-1355. doi: 10.1016/j.kint.2017.07.021. Epub 2017 Sep 28.
5
Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.活检与外周计算机断层扫描在评估透析的慢性肾脏病患者骨病中的应用：差异与相似之处
Osteoporos Int. 2017 May;28(5):1675-1683. doi: 10.1007/s00198-017-3956-9. Epub 2017 Feb 16.
6
Romosozumab successfully regulated progressive osteoporosis in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis.罗莫佐单抗成功调节了一名接受血液透析的常染色体显性多囊肾病患者的进行性骨质疏松症。
Osteoporos Int. 2022 Dec;33(12):2649-2652. doi: 10.1007/s00198-022-06534-4. Epub 2022 Aug 18.
7
Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.血液透析患者骨矿物质密度与骨转换生化标志物之间的关系
Adv Ther. 2007 Sep-Oct;24(5):987-95. doi: 10.1007/BF02877703.
8
Management of osteoporosis in patients with chronic kidney disease.慢性肾脏病患者骨质疏松症的管理。
Osteoporos Int. 2022 Nov;33(11):2259-2274. doi: 10.1007/s00198-022-06462-3. Epub 2022 Jun 24.
9
Bisphophonates in CKD patients with low bone mineral density.双膦酸盐用于骨矿物质密度低的慢性肾脏病患者。
ScientificWorldJournal. 2013 Dec 31;2013:837573. doi: 10.1155/2013/837573. eCollection 2013.
10
[Fragility fracture in the Chronic Kidney Disease (CKD)].[慢性肾脏病（CKD）中的脆性骨折]
G Ital Nefrol. 2017 Dec 5;34(Nov-Dec):2017-vol6.
引用本文的文献
1
Impact of serum magnesium and bone mineral density on systemic fractures in chronic hemodialysis patients.血清镁和骨密度对慢性血液透析患者全身骨折的影响。
PLoS One. 2021 May 20;16(5):e0251912. doi: 10.1371/journal.pone.0251912. eCollection 2021.
2
Kidney Stones and Risk of Osteoporotic Fracture in Chronic Kidney Disease.慢性肾脏病患者肾结石与骨质疏松性骨折风险。
Sci Rep. 2019 Feb 13;9(1):1929. doi: 10.1038/s41598-018-38191-1.
3
Rethinking Bone Disease in Kidney Disease.重新审视肾病中的骨病
JBMR Plus. 2018 Nov 15;2(6):309-322. doi: 10.1002/jbm4.10117. eCollection 2018 Nov.
4
Vitamin D, a modulator of musculoskeletal health in chronic kidney disease.维生素 D：慢性肾脏病中骨骼肌肉健康的调节剂。
J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):686-701. doi: 10.1002/jcsm.12218. Epub 2017 Jul 3.
5
High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.高甲状旁腺激素水平和骨质疏松症预示着透析患者冠状动脉钙化的进展。
J Am Soc Nephrol. 2015 Oct;26(10):2534-44. doi: 10.1681/ASN.2014070686. Epub 2015 Apr 2.
本文引用的文献
1
Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.慢性肾脏病透析患者骨量丢失的骨密度及血清生化预测指标
Clin J Am Soc Nephrol. 2014 Jul;9(7):1254-62. doi: 10.2215/CJN.09470913. Epub 2014 Jun 19.
2
Kidney transplantation with early corticosteroid withdrawal: paradoxical effects at the central and peripheral skeleton.肾移植后早期撤停皮质类固醇：对中枢和外周骨骼的矛盾影响。
J Am Soc Nephrol. 2014 Jun;25(6):1331-41. doi: 10.1681/ASN.2013080851. Epub 2014 Feb 7.
3
The three-year incidence of fracture in chronic kidney disease.慢性肾脏病患者骨折的三年发生率。
Kidney Int. 2014 Oct;86(4):810-8. doi: 10.1038/ki.2013.547. Epub 2014 Jan 15.
4
Increased bone fractures among elderly United States hemodialysis patients.美国老年血液透析患者骨折发生率增加。
Nephrol Dial Transplant. 2014 Jan;29(1):146-51. doi: 10.1093/ndt/gft352. Epub 2013 Sep 26.
5
Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation.移植肾五年后，持续性甲状旁腺功能亢进是骨折的一个主要危险因素。
Am J Transplant. 2013 Oct;13(10):2653-63. doi: 10.1111/ajt.12425. Epub 2013 Aug 26.
6
Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States.美国开始透析治疗的老年髋部骨折患者的发病率、治疗和结局的时间趋势。
Clin J Am Soc Nephrol. 2013 Aug;8(8):1336-42. doi: 10.2215/CJN.10901012. Epub 2013 May 9.
7
Rapid cortical bone loss in patients with chronic kidney disease.慢性肾脏病患者的快速皮质骨丢失。
J Bone Miner Res. 2013 Aug;28(8):1811-20. doi: 10.1002/jbmr.1916.
8
Bone mineral density and fracture risk in older individuals with CKD.老年慢性肾脏病患者的骨密度与骨折风险。
Clin J Am Soc Nephrol. 2012 Jul;7(7):1130-6. doi: 10.2215/CJN.12871211. Epub 2012 Apr 19.
9
Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease.DXA 和 HR pQCT 测定的骨密度可区分 3 至 5 期慢性肾脏病男性和女性的骨折状态。
Osteoporos Int. 2012 Dec;23(12):2805-13. doi: 10.1007/s00198-012-1908-y.
10
Discriminants of prevalent fractures in chronic kidney disease.慢性肾脏病患者骨折的鉴别诊断。
J Am Soc Nephrol. 2011 Aug;22(8):1560-72. doi: 10.1681/ASN.2010121275. Epub 2011 Jul 22.
Zotero 插件